Press "Enter" to skip to content

New patent for NOVO drug FIASP FLEXTOUCH

0
Copyright © DrugPatentWatch. Originally published at New patent for NOVO drug FIASP FLEXTOUCH

Annual Drug Patent Expirations for FIASP+FLEXTOUCH
Annual Drug Patent Expirations for FIASP+FLEXTOUCH

Fiasp Flextouch is a drug marketed by Novo and is included in one NDA. It is available from one supplier. There are fourteen patents protecting this drug.

Drug patent litigation for FIASP FLEXTOUCH.

This drug has one hundred and thirteen patent family members in twenty-one countries.

The generic ingredient in FIASP FLEXTOUCH is insulin aspart. One supplier is listed for this compound. Additional details are available on the insulin aspart profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for NOVO drug FIASP FLEXTOUCH
    Do NOT follow this link or you will be banned from the site!